Streetbeat News

Price Targets

MRNS

Over the past 3 months, 5 Wall Street analysts have provided ratings for Marinus Pharma (NASDAQ:MRNS), with 3 being bullish and 2 somewhat bullish. There have been no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for MRNS is $25.6, with a high of $28.00 and a low of $21.00. This target has decreased by 1.54% from the previous target of $26.00. Analyst ratings are important as they provide investors with specialized advice on stock performance, though they may be subject to error.

Portfolio Pulse from Benzinga Insights

December 05, 2023 | 6:00 pm

MAR

Marriott Intl (NASDAQ:MAR) has received mixed analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 2 indifferent ratings. No somewhat bearish or bearish ratings were reported. The average 12-month price target among 6 analysts is $224.33, with a high of $233.00 and a low of $215.00. This target has increased by 7.68% over the past month, indicating a positive shift in analyst sentiment.

Portfolio Pulse from Benzinga Insights

December 05, 2023 | 6:00 pm

MAR

Wells Fargo analyst Daniel Politzer has initiated coverage on Marriott International (NASDAQ:MAR) with an Equal-Weight rating and set a price target of $220 for the stock.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:46 pm

H

Wells Fargo analyst Daniel Politzer has initiated coverage on Hyatt Hotels with an Overweight rating and set a price target of $138. This new coverage could influence investor sentiment and potentially impact Hyatt's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:42 pm

GTLB

Scotiabank analyst Nick Altmann has maintained a Sector Outperform rating on GitLab (NASDAQ:GTLB) and increased the price target from $60 to $70.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:34 pm

AGRO

Adecoagro's stock (AGRO) has been upgraded by B of A Securities from Neutral to Buy, with a price target increase from $12.5 to $14, leading to higher trading of its shares.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:30 pm

SQ

BMO Capital analyst Rufus Hone has initiated coverage on Block (NYSE:SQ) with an Outperform rating, while reducing the price target to $84.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:27 pm

HPP

BMO Capital analyst John Kim has maintained an Outperform rating on Hudson Pacific Properties (NYSE:HPP) and increased the price target from $10 to $11.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:24 pm

KEY

KeyCorp shares are trading lower following the company's issuance of weak Q4 guidance. Concurrently, RBC Capital has maintained an Outperform rating on KeyCorp but reduced its price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:23 pm

IMXI

BMO Capital analyst Rufus Hone has assumed coverage on IntL Money Express (NASDAQ:IMXI) with an Outperform rating and increased the price target to $30.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 5:22 pm